Akay Natural Ingredients Private Limited

TGA BioServices, an Absorption Systems'​ Company, is an FDA inspected contract research laboratory providing the Pharmaceutical, Biotechnology and Research communities a comprehensive range of laboratory services in support of research and clinical studies. We offer the client a complete package of customized testing systems utilized in preclinical through Phase IV studies, all in compliance with cGLP and cGMP requirements.

We specialize in the development and validation of immunoassay systems for the detection of target molecules, antibody responses and quantification in total compliance with QA and cGMP standards.

TGA BioServices also offers in vivo mouse studies for the optimization of vaccine immunization schedules, dosing, adjuvant screening, immunogenicity testing for the release and stability of bulk and finished clinical product, as well as complete antibody development programs. Furthermore, we offer Guinea pig dermal sensitization testing for the identification of contact allergens. All programs are supervised by an in-house Institutional Animal Care and Use Committee (IACUC), while the facility is USDA registered and AAALAC accredited.

Other services provided include FACScan cell labeling studies, tissue culture, endotoxin testing, basic R&D activities, sample storage, specimen collection kits with on-site training, data management, protocol generation (SOP), database/statistical analysis and consultation. TGA BioServices has the credentials your project is searching for.

Disphar International B.V. is specialised in development and registration of high quality pharmaceutical medicines/registration dossiers with focus on Geographical Europe and foothold in Middle East, Asia, Africa, South America.
We have a strong internal co-ordination by project-management teams with highly skilled people and are a partner to all major generic players and innovative pharma industry for development and/or regulatory affairs/supply.

We offer to generic and innovative industry:
* Broad portfolio of EU (e)CTD dossiers from own development and collaborations;
* Marketing authorisations for generics & Value-Added Pharmaceuticals;
* Product development (R&D) Services in the broadest sense at Indeus Lab;
* Clinical services (trials, bioequivalence studies, etc) at Prague Clinical Studies, also belonging to Nordic Pharma Group;
* Supply of finished dosage forms (finished packs or bulk);
* QA/QC services.
* Partnership & Co-development

Disphar International B.V. is a member of the Nordic Pharma Group since 2001.
In Sep 2009 Indeus Life Sciences was established, which is operating as our development and laboratory site and can offer development oppertunities, stability studies, etc for external partners.

If you are interested in the services or products of Disphar International or Indeus Life Sciences, please feel free to call or email us (see contact details under the "Products & Services tab"​ and on our website, www.disphar.com).

ACIES BIO is a biotechnology contract research organization offering state-of-the-art R&D services to pharmaceutical, chemical, biotech and food industries. We provide full support from idea conceptualization through research to product development. Combining biotechnology and synthetic organic chemistry expertise, we offer a comprehensive service, covering all key development steps for efficient production of biosynthetic natural products or their semi-synthetic derivatives, as well as entirely synthetic compounds.

Working with some of the largest international companies, we provide to our clients full R&D support both in our laboratories as well as on-site at the client’s facilities.

With experience and know-how in natural product (bio)synthesis, milestone-based approach to projects, innovativeness and flexibility, as well as competitive pricing, ACIES BIO aims to become the premier partner in R&D outsourcing for pharmaceutical companies.

Absolute Research Solutions was created to assist pharmaceutical companies in the successful and timely completion of their trials. Through over ten years of clinical trials experience, our consultants have been involved in all phases of the drug development process.

We understand that without qualified evaluable patients and quality data, your success will be impossible. We can assist in all phases of development...

Our multi specialty investigative site has extensive experience in both in and out patient protocols with a proven track record for success. Our study coordinators have conducted over 100 protocols and are continuously receiving training to stay up to date on all new regulations.

Our consultants can assist you in all phases of your project, from site selection to QA audits to project management to contract monitoring. Our experience and expertise speaks for itself. In this changing world of clinical trials it's good to have a resource who understands the logistics of running an investigative site in today's competitive market What it takes to strategically locate your patient population and to accurately execute the protocol.

Evotec is a life science company with a unique business model that delivers on its mission to discover and develop highly effective therapeutics and make them available to the patients. The Company’s multimodality platform comprises a unique combination of innovative technologies, data and science for the discovery, development, and production of first-in-class and best-in-class pharmaceutical products. Evotec leverages this “Data-driven R&D Autobahn to Cures” for proprietary projects and within a network of partners including all Top 20 Pharma and over 800 biotechnology companies, academic institutions, as well as other healthcare stakeholders. Evotec has strategic activities in a broad range of currently underserved therapeutic areas, including e.g. neurology, oncology, as well as metabolic and infectious diseases. Within these areas of expertise, Evotec aims to create the world-leading co-owned pipeline for innovative therapeutics and has to-date established a portfolio of more than 200 proprietary and co-owned R&D projects from early discovery to clinical development. Evotec operates globally with more than 3,700 highly qualified people. The Company’s 14 sites offer highly synergistic technologies and services and operate as complementary clusters of excellence.